Filing Flows › Harvard Apparatus Regenerative Technology (HRGN) › Q4 2025
Harvard Apparatus Regenerative Technology (HRGN) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Mar 19, 2026
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $219K for the fourth quarter 2025 (Q4 2025), -15% from a year earlier and +78% from the quarter before. Operating margin was -775.3%, net loss $1.7M (770.3% of revenue).
Harvard Apparatus Regenerative Technology, Q4 2025: revenue $219K (-15% year over year), operating margin -775.3%, net loss $1.7M, operating cash flow −$664K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $219K | +78% | -15% |
| Operating profit | −$1.7M | — | — |
| Net earnings | −$1.7M | — | — |
| Operating cash flow | −$664K | — | — |
What changed
Revenue was $219K in Q4 2025, down 15% year over year and up 78% from the previous quarter.
Operating costs exceeded revenue by $1.7M, an operating margin of -775.3%. Total costs grew 18% against a revenue fall of 15%. The fastest-growing cost line was Research & development (+158%). The quarter ended with a net loss of $1.7M, narrower than the previous quarter's $1.7M loss.
Operating cash flow was −$664K. Non-cash charges added back $1K of depreciation and $493K of share-based compensation. Working capital and other items added $529K.
Questions
What was Harvard Apparatus Regenerative Technology's revenue in the fourth quarter 2025?
Harvard Apparatus Regenerative Technology (HRGN) reported revenue of $219K for the fourth quarter 2025 (Q4 2025), -15% from a year earlier and +78% from the quarter before.
Was Harvard Apparatus Regenerative Technology profitable in the fourth quarter 2025?
Operating loss was $1.7M (-775.3% of revenue) and net loss $1.7M.
Source: Harvard Apparatus Regenerative Technology 10-K on SEC EDGAR.